![Autoantibodies and Their Role in Scleroderma Clinical Care | Current Treatment Options in Rheumatology Autoantibodies and Their Role in Scleroderma Clinical Care | Current Treatment Options in Rheumatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40674-016-0050-y/MediaObjects/40674_2016_50_Fig1_HTML.gif)
Autoantibodies and Their Role in Scleroderma Clinical Care | Current Treatment Options in Rheumatology
![RunTheList on X: "Keep in mind that some autoantibodies are *non-specific* While they can be detected in patients with myositis, they are also seen in other autoimmune disorders (e.g. Ro52 in scleroderma)! RunTheList on X: "Keep in mind that some autoantibodies are *non-specific* While they can be detected in patients with myositis, they are also seen in other autoimmune disorders (e.g. Ro52 in scleroderma)!](https://pbs.twimg.com/media/Ety4tN3XcAcA-Sn.jpg)
RunTheList on X: "Keep in mind that some autoantibodies are *non-specific* While they can be detected in patients with myositis, they are also seen in other autoimmune disorders (e.g. Ro52 in scleroderma)!
![What are the new milestones in the pathogenesis of systemic sclerosis? | Annals of the Rheumatic Diseases What are the new milestones in the pathogenesis of systemic sclerosis? | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/69/Suppl_1/i52/F1.large.jpg)
What are the new milestones in the pathogenesis of systemic sclerosis? | Annals of the Rheumatic Diseases
![Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease - Page 10 of 11 - The Rheumatologist Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease - Page 10 of 11 - The Rheumatologist](https://www.the-rheumatologist.org/wp-content/uploads/springboard/image/THR_Dec_2014_pp87_t01_LG.jpg)
Laboratory Testing for Diagnosis, Management of Patients with Rheumatic Disease - Page 10 of 11 - The Rheumatologist
![Cells | Free Full-Text | Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis Cells | Free Full-Text | Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis](https://pub.mdpi-res.com/cells/cells-10-03402/article_deploy/html/images/cells-10-03402-g001-550.jpg?1638545802)
Cells | Free Full-Text | Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis
![Frontiers | Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification Frontiers | Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification](https://www.frontiersin.org/files/Articles/587773/fmed-07-587773-HTML/image_m/fmed-07-587773-t003.jpg)
Frontiers | Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification
![Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors](https://www.frontiersin.org/files/MyHome%20Article%20Library/433394/433394_Thumb_400.jpg)
Frontiers | Intriguing Relationships Between Cancer and Systemic Sclerosis: Role of the Immune System and Other Contributors
![Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology](https://www.thelancet.com/cms/asset/4f5745bf-41f7-4fed-89f9-32aea00e28ca/gr1.jpg)
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology
![Biomarkers in systemic sclerosis: Their potential to predict clinical courses - Hasegawa - 2016 - The Journal of Dermatology - Wiley Online Library Biomarkers in systemic sclerosis: Their potential to predict clinical courses - Hasegawa - 2016 - The Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/ce26be22-933c-456a-9e13-9ba34b3380f2/jde13156-fig-0002-m.jpg)
Biomarkers in systemic sclerosis: Their potential to predict clinical courses - Hasegawa - 2016 - The Journal of Dermatology - Wiley Online Library
![Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets - ScienceDirect Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1568997220301476-gr1.jpg)
Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets - ScienceDirect
![Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology](https://www.thelancet.com/cms/attachment/90f0f1bc-5cf1-42e7-a6de-3aab31c1e53f/gr2_lrg.jpg)
Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine - The Lancet Rheumatology
![Seroconversion from Anti-Th/To to Anticentromere Antibodies in a Patient with Systemic Sclerosis | The Journal of Rheumatology Seroconversion from Anti-Th/To to Anticentromere Antibodies in a Patient with Systemic Sclerosis | The Journal of Rheumatology](https://www.jrheum.org/content/jrheum/44/12/1938/F1.large.jpg?download=true)
Seroconversion from Anti-Th/To to Anticentromere Antibodies in a Patient with Systemic Sclerosis | The Journal of Rheumatology
Tumor Necrosis Factor α Inhibitor–Induced Lupuslike Syndrome in a Patient Prescribed Certolizumab Pegol | MDedge Dermatology
![Frontiers | Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification Frontiers | Classical Disease-Specific Autoantibodies in Systemic Sclerosis: Clinical Features, Gene Susceptibility, and Disease Stratification](https://www.frontiersin.org/files/Articles/587773/fmed-07-587773-HTML/image_m/fmed-07-587773-t002.jpg)